- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 24, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A story on PatientEngagementHIT referenced a study published in the September 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “Using CAHPS Patient Experience Data for Patient-Centered Medical Home Transformation,” found that Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys were considered actionable for primary care practices to use in patient-centered medical home transformation and in standardizing and coordinating care.
An article on RevCycleIntelligence highlighted a study in the July 2021 issue of AJMC®. The study, “Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices,” found that market power is low in most metropolitan statistical areas for self-insured employers to negotiate hospital prices.
A story published on Spectrum News NY1 referred to an article published last year on AJMC.com, the website of AJMC®. The article, “Cancer Care Delays in COVID-19 Could Lead to Higher Morbidity, Mortality,” noted the fears experts have about the effect of delayed cancer screenings and treatments as a result of the pandemic.
An article published on BioWorld referenced "Biosimilars Roundup: Policy and Business Developments Signify a Busy August," a monthly column published on The Center for Biosimilars®, which discussed a controversy over payer policies for bevacizumab biosimilars.
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
Rozanolixizumab Effective in Patients with MuSK MG, Analysis Shows
October 23rd 2024A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
